SlideShare a Scribd company logo
1 of 16
“ The Unfortunate Experiment” a  very  abbreviated tale   Rachel Walden
Cervical Cancer a few terms, courtesy of the NCI   Cervical cancer:  Cancer that forms in tissues of the cervix (organ connecting the uterus and vagina). It is usually a slow-growing cancer that may not have symptoms, but can be found with regular Pap smears (procedure in which cells are scraped from the cervix and looked at under a microscope). Stage 0:  The cancer is found only in the top layer of cells in the tissue that lines the cervix. Stage 0 is also called  carcinoma in situ . Properly treated, tumor control of in situ cervical carcinoma should be nearly 100%.  Punch biopsy : a sharp, hollow device is used to remove sample of cervical tissue.  Cone biopsy:  removes a cone-shaped sample of tissue.
The Experiment Conducted at National Women’s Hospital, Auckland, New Zealand Headed by Dr. Herbert Green, OB/GYN at NWH, professor 948 patients with carcinoma in situ (CIS) of the cervix Women followed from 1955 to 1976; study officially began in 1966 To prove that CIS never develops into invasive cervical cancer, is not a premalignant condition To reduce number of major/invasive procedures to treat CIS, such as hysterectomy
The Methodology NWH patients recruited with cervical CIS who were under 35 yo, there were to be no signs of invasive carcinoma Followed from 5 to 28 years Split into groups by normal (A) or abnormal (B) cytology at follow up Received cone biopsies and other diagnostic procedures – not complete cancer removal
The Results 1.5% of group A and 22% of group B developed invasive cancer Women with continuing abnormal cytology 24.8 times more likely to develop invasive carcinoma In group A (normal follow-up), 3.2 times more likely to develop cancer than women who never had CIS Some women later died Green reclassified some of those who developed invasive cancer as having been missed initially
The Controversy In 1987, women’s health activists published an article, “An Unfortunate Experiment,” in the Metro magazine outlining the study. This article focused on one patient, “Ruth,” who was followed from 1964 to 1979, and finally diagnosed with cervical cancer in 1985.  Public outcry occurred, and judicial inquiry ordered by the Ministry of Health Cartwright inquiry – officially, “Committee of Inquiry into Allegations Concerning the Treatment of Cervical Cancer at National Women’s Hospital and into Other Related Matters,” headed by District Court Judge Silvia Cartwright 67 witnesses heard and >80 patients interviewed privately Report released August 5, 1988
The Inquiry Findings Determined that the study was unethical: women not informed they were in a study; not informed of other treatment options; inadequately addressed risks to patients; symptoms of invasive disease downplayed or overlooked; some women never even told they had CIS Dr. Green maintained it was not in the women’s interests to tell them what he was doing Other revelations: medical students were doing vaginal exams on anaesthetized women without their knowledge or consent; >2,000 newborn females received cervical smears; some women later enrolled in R Series trial of differing treatments of invasive cancer without their knowledge
The Inquiry, continued Early attempts at questioning the by the cytologist and pathologist program went nowhere – Superintendent-in-Chief of the Auckland Medical Board did not consider the matter “urgent” Other clinicians did not want to interfere with Dr. Green’s “clinical freedom”  Cases of invasive cancer were identified in 1969, but trial continued Enrollment protocol not followed – women over 35 were included fairly regularly, invasive signs ignored Numerous recommendations for improvement: patient advocates, nationwide cervical cancer screening, improved informed consent, ethics
Women’s Statements “I can’t explain the shock that I felt when I found out by accident that I had a cone biopsy.” “…I was never actually told that I had carcinoma in situ.” “After I had the cone biopsy I was told that they had got it all. I have since learnt that this was not the case. I was told that the chance of getting any form of cancer again were the same as any other woman.” “For instance, if I had known that my biopsy in 1975 showed that I had microinvasion, I would never have ceased to go to follow-up clinics.”
Historical Context Declaration of Helsinki written in 1964; Nuremburg Code also in existence at time of study According to the Cartwright report: “By the early 1960s most experts in Europe, the United States of America and Australia considered that CIS was a precursor of invasive cervical cancer.”  Indirect and direct evidence was in existence when study began that CIS could in fact lead to invasive cancer Less invasive management techniques were already gaining favor before 1966
The Aftermath ~130 patients identified and contacted for follow-up. This was not perfect, as follow-up sometimes occurred in the course of routine clinical care, without women being provided with full details of their past enrollment into Dr. Green’s study Bureaucracy and resistance slows action on Cartwright report recommendations. Some physicians call informed consent procedures too burdensome.  Cartwright Inquiry challenged, attacked as a “feminist witch hunt,” but later vindicated Some physicians investigated and fined. Dr. Green not punished due to poor health.   Several women sue and receive damages. In the 1990s a related inquiry occurs, after it is found that abnormal cervical smear results have been vastly underreported in one region of the national cervical cancer screening program. More women die of cervical cancer as a result.
Summary Study based on personal beliefs rather than established facts Informed consent – completely absent  Lack of understanding and voluntariness Respect for persons – individuals not treated as autonomous agents Justice – subjects were chosen because they were available Beneficence – no efforts to minimize harm Questionable handling of adverse events Institutional safeguards broken/not followed Hypothesis disproved; trial continued
Resources Campbell AV. A report from New Zealand: an ‘unfortunate experiment.’ Bioethics. 1989 Jan;3(1):59-66. Committee on Inquiry into Allegations Concerning the Treatment of Cervical Cancer at National Women’s Hospital and into Other Related Matters. Report of the Committee of Inquiry into Allegations Concerning the Treatment of Cervical Cancer at National Women’s Hospital and into Other Related Matters. Auckland: The Committee, 1988.  Davis P. A fortunate inquest: the report of the cervical cancer inquiry. Community Health Stud. 1988;12(3):246-50. Coney S, ed. Unfinished business: what happened to the Cartwright Report?: writings on the aftermath of 'the unfortunate experiment' at National Women's Hospital. Auckland: Women’s Health Action, 1993. Coney S. The Unfortunate Experiment. Auckland: Penguin Books, 1988.
Resources - 2 Flagler EA, Winkler ER. ‘An unfortunate experiment’: the New Zealand study of cancer of the cervix. Ann R Coll Physicians Surg Can. 1992 Apr;25(2):124-30. Heslop B. ‘All about research’ – looking back at the 1987 Cervical Cancer Inquiry. N Z Med J. 2004 Aug 6;117(1199):U1000.  McIndoe WA, McLean MR, Jones RW, Mullins PR. The invasive potential of carcinoma in situ of the cervix. Obstet Gynecol. 1984 Oct;64(4):451-8. Munro K. The aftermath of the cervical caner inquiry in New Zealand: an antipodal aberration or universal struggle? Issues Reprod Genet Eng. 1991;4(1):31-9. Paul C. Internal and external morality of medicine: lessons from New Zealand. BMJ. 2000 Feb;320(7233):499-503.
Resources - 3 Rosier P. The speculum bites back: feminists spark an inquiry into the treatment of carcinoma in situ at Auckland’s National Women’s Hospital. Reprod Genet Eng. 1989;2(2):121-32.  Williams L. Looking back at the 1987 Cervical Cancer Inquiry. N Z Med J. 2004 Sep 24;117(1202):U1084; author reply U1084.  Women’s Health Action Trust. Women’s Health Action [web document]. Auckland: The Trust. [rev. 28 Dec 2005; cited 18 Apr 2006]. <http://www.womens-health.org.nz/>
Special Thanks to the EBL Document Delivery staff These amazing folks obtained a copy of  the  Cartwright Report, held by fewer than 20 libraries in the United States!

More Related Content

What's hot

Physical Assessment strategies & Technique.pptx
Physical Assessment strategies & Technique.pptxPhysical Assessment strategies & Technique.pptx
Physical Assessment strategies & Technique.pptxMustafaALShlash1
 
Callista Roy Model
Callista Roy ModelCallista Roy Model
Callista Roy Modelmaryamnoor21
 
The use of meta -analysis for Pharmacoepidemiology
The use of meta -analysis for PharmacoepidemiologyThe use of meta -analysis for Pharmacoepidemiology
The use of meta -analysis for Pharmacoepidemiologykamolwantnok
 
N212 Theory: Jean Watson Presentation
N212 Theory: Jean Watson PresentationN212 Theory: Jean Watson Presentation
N212 Theory: Jean Watson PresentationMegan A
 
Chapter05
Chapter05Chapter05
Chapter05bholmes
 
Calculation of drug dosage (Posology )
Calculation of drug dosage (Posology )Calculation of drug dosage (Posology )
Calculation of drug dosage (Posology )Amit Kumar
 
Newer Methods of Assessment in Medical Education
Newer Methods of Assessment in  Medical EducationNewer Methods of Assessment in  Medical Education
Newer Methods of Assessment in Medical EducationSwati Deshpande
 
About nursing careers information
About nursing careers informationAbout nursing careers information
About nursing careers informationBrian Ross
 

What's hot (11)

Physical Assessment strategies & Technique.pptx
Physical Assessment strategies & Technique.pptxPhysical Assessment strategies & Technique.pptx
Physical Assessment strategies & Technique.pptx
 
Callista Roy Model
Callista Roy ModelCallista Roy Model
Callista Roy Model
 
The use of meta -analysis for Pharmacoepidemiology
The use of meta -analysis for PharmacoepidemiologyThe use of meta -analysis for Pharmacoepidemiology
The use of meta -analysis for Pharmacoepidemiology
 
Medical ethics
Medical ethicsMedical ethics
Medical ethics
 
N212 Theory: Jean Watson Presentation
N212 Theory: Jean Watson PresentationN212 Theory: Jean Watson Presentation
N212 Theory: Jean Watson Presentation
 
Kings theory20(1)
Kings theory20(1)Kings theory20(1)
Kings theory20(1)
 
Chapter05
Chapter05Chapter05
Chapter05
 
5.ภาควิชานิติเวชศาสตร์
5.ภาควิชานิติเวชศาสตร์5.ภาควิชานิติเวชศาสตร์
5.ภาควิชานิติเวชศาสตร์
 
Calculation of drug dosage (Posology )
Calculation of drug dosage (Posology )Calculation of drug dosage (Posology )
Calculation of drug dosage (Posology )
 
Newer Methods of Assessment in Medical Education
Newer Methods of Assessment in  Medical EducationNewer Methods of Assessment in  Medical Education
Newer Methods of Assessment in Medical Education
 
About nursing careers information
About nursing careers informationAbout nursing careers information
About nursing careers information
 

Viewers also liked

Radiation induced sarcomas in head and neck
Radiation induced sarcomas in head and neckRadiation induced sarcomas in head and neck
Radiation induced sarcomas in head and neckSheh Rawat
 
Mission SAY No to Cervical Cancer With HPV Vaccination DR. SHARDA JAIN S...
Mission SAY No to Cervical Cancer   With HPV Vaccination DR. SHARDA JAIN  S...Mission SAY No to Cervical Cancer   With HPV Vaccination DR. SHARDA JAIN  S...
Mission SAY No to Cervical Cancer With HPV Vaccination DR. SHARDA JAIN S...Lifecare Centre
 
HPV Diseases More Than Cervical Cancer, Dr. Sharda Jain
HPV Diseases More Than Cervical Cancer, Dr. Sharda Jain HPV Diseases More Than Cervical Cancer, Dr. Sharda Jain
HPV Diseases More Than Cervical Cancer, Dr. Sharda Jain Lifecare Centre
 
Screening for cervical cancer
Screening for  cervical cancerScreening for  cervical cancer
Screening for cervical cancerAboubakr Elnashar
 
Latest update on cervical cancer & hpv vaccine 2013
Latest update on cervical cancer & hpv vaccine   2013Latest update on cervical cancer & hpv vaccine   2013
Latest update on cervical cancer & hpv vaccine 2013Lifecare Centre
 
Presentation on cervical cancer
Presentation on cervical cancerPresentation on cervical cancer
Presentation on cervical cancerlok kathayat
 

Viewers also liked (6)

Radiation induced sarcomas in head and neck
Radiation induced sarcomas in head and neckRadiation induced sarcomas in head and neck
Radiation induced sarcomas in head and neck
 
Mission SAY No to Cervical Cancer With HPV Vaccination DR. SHARDA JAIN S...
Mission SAY No to Cervical Cancer   With HPV Vaccination DR. SHARDA JAIN  S...Mission SAY No to Cervical Cancer   With HPV Vaccination DR. SHARDA JAIN  S...
Mission SAY No to Cervical Cancer With HPV Vaccination DR. SHARDA JAIN S...
 
HPV Diseases More Than Cervical Cancer, Dr. Sharda Jain
HPV Diseases More Than Cervical Cancer, Dr. Sharda Jain HPV Diseases More Than Cervical Cancer, Dr. Sharda Jain
HPV Diseases More Than Cervical Cancer, Dr. Sharda Jain
 
Screening for cervical cancer
Screening for  cervical cancerScreening for  cervical cancer
Screening for cervical cancer
 
Latest update on cervical cancer & hpv vaccine 2013
Latest update on cervical cancer & hpv vaccine   2013Latest update on cervical cancer & hpv vaccine   2013
Latest update on cervical cancer & hpv vaccine 2013
 
Presentation on cervical cancer
Presentation on cervical cancerPresentation on cervical cancer
Presentation on cervical cancer
 

Similar to New Zealand Cervical Cancer Experiment

Recover from cancer diagnosis
Recover from cancer diagnosisRecover from cancer diagnosis
Recover from cancer diagnosisJohn Bergman
 
What Black Women Need to Know About Endometrial Cancer
What Black Women Need to Know About Endometrial CancerWhat Black Women Need to Know About Endometrial Cancer
What Black Women Need to Know About Endometrial Cancerbkling
 
Cervcal cancer prevention in sa
Cervcal cancer prevention in saCervcal cancer prevention in sa
Cervcal cancer prevention in saTariq Mohammed
 
Risk Factors of Cervical Cancer.pdf
Risk Factors of Cervical Cancer.pdfRisk Factors of Cervical Cancer.pdf
Risk Factors of Cervical Cancer.pdfYelmi Reni Putri SY
 
Finding a Clinical Trial That's Right for You
Finding a Clinical Trial That's Right for YouFinding a Clinical Trial That's Right for You
Finding a Clinical Trial That's Right for Youbkling
 
SUO_HCM4004_W2_A2_Estevez_Maria.docxby Maria Estevez.docx
SUO_HCM4004_W2_A2_Estevez_Maria.docxby Maria Estevez.docxSUO_HCM4004_W2_A2_Estevez_Maria.docxby Maria Estevez.docx
SUO_HCM4004_W2_A2_Estevez_Maria.docxby Maria Estevez.docxpicklesvalery
 
Dindigul district cervical screening study, india acceptability, effectivenes...
Dindigul district cervical screening study, india acceptability, effectivenes...Dindigul district cervical screening study, india acceptability, effectivenes...
Dindigul district cervical screening study, india acceptability, effectivenes...Asha Reddy
 
Clinical Study of Benign Breast Diseases
Clinical Study of Benign Breast DiseasesClinical Study of Benign Breast Diseases
Clinical Study of Benign Breast Diseasesiosrjce
 
MN Cancer Summit - February 28, 2019 - Mid-Day Plenary Speaker Presentation
MN Cancer Summit - February 28, 2019 - Mid-Day Plenary Speaker PresentationMN Cancer Summit - February 28, 2019 - Mid-Day Plenary Speaker Presentation
MN Cancer Summit - February 28, 2019 - Mid-Day Plenary Speaker PresentationEmil Lou, M.D., Ph.D, FACP
 
Assignment 2 Final Project Part III Designing a StudyYou are t.docx
Assignment 2 Final Project Part III Designing a StudyYou are t.docxAssignment 2 Final Project Part III Designing a StudyYou are t.docx
Assignment 2 Final Project Part III Designing a StudyYou are t.docxrock73
 
Screening in carcinoma breast
Screening in carcinoma breast Screening in carcinoma breast
Screening in carcinoma breast pgclubrcc
 
DES Update CDC 2003
DES Update CDC 2003DES Update CDC 2003
DES Update CDC 2003DES Daughter
 
Diagnosed with breast cancer while on a family historyscreen.docx
Diagnosed with breast cancer while on a family historyscreen.docxDiagnosed with breast cancer while on a family historyscreen.docx
Diagnosed with breast cancer while on a family historyscreen.docxduketjoy27252
 
Diagnosed with breast cancer while on a family historyscreen.docx
Diagnosed with breast cancer while on a family historyscreen.docxDiagnosed with breast cancer while on a family historyscreen.docx
Diagnosed with breast cancer while on a family historyscreen.docxlynettearnold46882
 
Chinese and Vietnamese Perceptions of Cervical Cancer and Medical Research 10...
Chinese and Vietnamese Perceptions of Cervical Cancer and Medical Research 10...Chinese and Vietnamese Perceptions of Cervical Cancer and Medical Research 10...
Chinese and Vietnamese Perceptions of Cervical Cancer and Medical Research 10...Leonard Davis Institute of Health Economics
 

Similar to New Zealand Cervical Cancer Experiment (20)

Recover from cancer diagnosis
Recover from cancer diagnosisRecover from cancer diagnosis
Recover from cancer diagnosis
 
What Black Women Need to Know About Endometrial Cancer
What Black Women Need to Know About Endometrial CancerWhat Black Women Need to Know About Endometrial Cancer
What Black Women Need to Know About Endometrial Cancer
 
Cervcal cancer prevention in sa
Cervcal cancer prevention in saCervcal cancer prevention in sa
Cervcal cancer prevention in sa
 
Risk Factors of Cervical Cancer.pdf
Risk Factors of Cervical Cancer.pdfRisk Factors of Cervical Cancer.pdf
Risk Factors of Cervical Cancer.pdf
 
WEBINAR: Breast Screening and Breast Density
WEBINAR: Breast Screening and Breast DensityWEBINAR: Breast Screening and Breast Density
WEBINAR: Breast Screening and Breast Density
 
Finding a Clinical Trial That's Right for You
Finding a Clinical Trial That's Right for YouFinding a Clinical Trial That's Right for You
Finding a Clinical Trial That's Right for You
 
SUO_HCM4004_W2_A2_Estevez_Maria.docxby Maria Estevez.docx
SUO_HCM4004_W2_A2_Estevez_Maria.docxby Maria Estevez.docxSUO_HCM4004_W2_A2_Estevez_Maria.docxby Maria Estevez.docx
SUO_HCM4004_W2_A2_Estevez_Maria.docxby Maria Estevez.docx
 
Dindigul district cervical screening study, india acceptability, effectivenes...
Dindigul district cervical screening study, india acceptability, effectivenes...Dindigul district cervical screening study, india acceptability, effectivenes...
Dindigul district cervical screening study, india acceptability, effectivenes...
 
Clinical Study of Benign Breast Diseases
Clinical Study of Benign Breast DiseasesClinical Study of Benign Breast Diseases
Clinical Study of Benign Breast Diseases
 
MN Cancer Summit - February 28, 2019 - Mid-Day Plenary Speaker Presentation
MN Cancer Summit - February 28, 2019 - Mid-Day Plenary Speaker PresentationMN Cancer Summit - February 28, 2019 - Mid-Day Plenary Speaker Presentation
MN Cancer Summit - February 28, 2019 - Mid-Day Plenary Speaker Presentation
 
Assignment 2 Final Project Part III Designing a StudyYou are t.docx
Assignment 2 Final Project Part III Designing a StudyYou are t.docxAssignment 2 Final Project Part III Designing a StudyYou are t.docx
Assignment 2 Final Project Part III Designing a StudyYou are t.docx
 
Dr. Obumneke Amadi-Onuoha Scripts- 5_ crit analysis_case study
Dr. Obumneke Amadi-Onuoha  Scripts- 5_ crit analysis_case studyDr. Obumneke Amadi-Onuoha  Scripts- 5_ crit analysis_case study
Dr. Obumneke Amadi-Onuoha Scripts- 5_ crit analysis_case study
 
Screening in carcinoma breast
Screening in carcinoma breast Screening in carcinoma breast
Screening in carcinoma breast
 
DES Update CDC 2003
DES Update CDC 2003DES Update CDC 2003
DES Update CDC 2003
 
Cervical cancer
Cervical cancerCervical cancer
Cervical cancer
 
Diagnosed with breast cancer while on a family historyscreen.docx
Diagnosed with breast cancer while on a family historyscreen.docxDiagnosed with breast cancer while on a family historyscreen.docx
Diagnosed with breast cancer while on a family historyscreen.docx
 
Diagnosed with breast cancer while on a family historyscreen.docx
Diagnosed with breast cancer while on a family historyscreen.docxDiagnosed with breast cancer while on a family historyscreen.docx
Diagnosed with breast cancer while on a family historyscreen.docx
 
WomensHealth_ITN0515
WomensHealth_ITN0515WomensHealth_ITN0515
WomensHealth_ITN0515
 
Chinese and Vietnamese Perceptions of Cervical Cancer and Medical Research 10...
Chinese and Vietnamese Perceptions of Cervical Cancer and Medical Research 10...Chinese and Vietnamese Perceptions of Cervical Cancer and Medical Research 10...
Chinese and Vietnamese Perceptions of Cervical Cancer and Medical Research 10...
 
Cancer Screening
Cancer ScreeningCancer Screening
Cancer Screening
 

Recently uploaded

Human Factors of XR: Using Human Factors to Design XR Systems
Human Factors of XR: Using Human Factors to Design XR SystemsHuman Factors of XR: Using Human Factors to Design XR Systems
Human Factors of XR: Using Human Factors to Design XR SystemsMark Billinghurst
 
My Hashitalk Indonesia April 2024 Presentation
My Hashitalk Indonesia April 2024 PresentationMy Hashitalk Indonesia April 2024 Presentation
My Hashitalk Indonesia April 2024 PresentationRidwan Fadjar
 
Swan(sea) Song – personal research during my six years at Swansea ... and bey...
Swan(sea) Song – personal research during my six years at Swansea ... and bey...Swan(sea) Song – personal research during my six years at Swansea ... and bey...
Swan(sea) Song – personal research during my six years at Swansea ... and bey...Alan Dix
 
Breaking the Kubernetes Kill Chain: Host Path Mount
Breaking the Kubernetes Kill Chain: Host Path MountBreaking the Kubernetes Kill Chain: Host Path Mount
Breaking the Kubernetes Kill Chain: Host Path MountPuma Security, LLC
 
AI as an Interface for Commercial Buildings
AI as an Interface for Commercial BuildingsAI as an Interface for Commercial Buildings
AI as an Interface for Commercial BuildingsMemoori
 
CloudStudio User manual (basic edition):
CloudStudio User manual (basic edition):CloudStudio User manual (basic edition):
CloudStudio User manual (basic edition):comworks
 
"LLMs for Python Engineers: Advanced Data Analysis and Semantic Kernel",Oleks...
"LLMs for Python Engineers: Advanced Data Analysis and Semantic Kernel",Oleks..."LLMs for Python Engineers: Advanced Data Analysis and Semantic Kernel",Oleks...
"LLMs for Python Engineers: Advanced Data Analysis and Semantic Kernel",Oleks...Fwdays
 
#StandardsGoals for 2024: What’s new for BISAC - Tech Forum 2024
#StandardsGoals for 2024: What’s new for BISAC - Tech Forum 2024#StandardsGoals for 2024: What’s new for BISAC - Tech Forum 2024
#StandardsGoals for 2024: What’s new for BISAC - Tech Forum 2024BookNet Canada
 
Pigging Solutions in Pet Food Manufacturing
Pigging Solutions in Pet Food ManufacturingPigging Solutions in Pet Food Manufacturing
Pigging Solutions in Pet Food ManufacturingPigging Solutions
 
SIEMENS: RAPUNZEL – A Tale About Knowledge Graph
SIEMENS: RAPUNZEL – A Tale About Knowledge GraphSIEMENS: RAPUNZEL – A Tale About Knowledge Graph
SIEMENS: RAPUNZEL – A Tale About Knowledge GraphNeo4j
 
Beyond Boundaries: Leveraging No-Code Solutions for Industry Innovation
Beyond Boundaries: Leveraging No-Code Solutions for Industry InnovationBeyond Boundaries: Leveraging No-Code Solutions for Industry Innovation
Beyond Boundaries: Leveraging No-Code Solutions for Industry InnovationSafe Software
 
Kotlin Multiplatform & Compose Multiplatform - Starter kit for pragmatics
Kotlin Multiplatform & Compose Multiplatform - Starter kit for pragmaticsKotlin Multiplatform & Compose Multiplatform - Starter kit for pragmatics
Kotlin Multiplatform & Compose Multiplatform - Starter kit for pragmaticscarlostorres15106
 
Artificial intelligence in the post-deep learning era
Artificial intelligence in the post-deep learning eraArtificial intelligence in the post-deep learning era
Artificial intelligence in the post-deep learning eraDeakin University
 
Automating Business Process via MuleSoft Composer | Bangalore MuleSoft Meetup...
Automating Business Process via MuleSoft Composer | Bangalore MuleSoft Meetup...Automating Business Process via MuleSoft Composer | Bangalore MuleSoft Meetup...
Automating Business Process via MuleSoft Composer | Bangalore MuleSoft Meetup...shyamraj55
 
Maximizing Board Effectiveness 2024 Webinar.pptx
Maximizing Board Effectiveness 2024 Webinar.pptxMaximizing Board Effectiveness 2024 Webinar.pptx
Maximizing Board Effectiveness 2024 Webinar.pptxOnBoard
 
Scanning the Internet for External Cloud Exposures via SSL Certs
Scanning the Internet for External Cloud Exposures via SSL CertsScanning the Internet for External Cloud Exposures via SSL Certs
Scanning the Internet for External Cloud Exposures via SSL CertsRizwan Syed
 
Designing IA for AI - Information Architecture Conference 2024
Designing IA for AI - Information Architecture Conference 2024Designing IA for AI - Information Architecture Conference 2024
Designing IA for AI - Information Architecture Conference 2024Enterprise Knowledge
 

Recently uploaded (20)

Human Factors of XR: Using Human Factors to Design XR Systems
Human Factors of XR: Using Human Factors to Design XR SystemsHuman Factors of XR: Using Human Factors to Design XR Systems
Human Factors of XR: Using Human Factors to Design XR Systems
 
My Hashitalk Indonesia April 2024 Presentation
My Hashitalk Indonesia April 2024 PresentationMy Hashitalk Indonesia April 2024 Presentation
My Hashitalk Indonesia April 2024 Presentation
 
E-Vehicle_Hacking_by_Parul Sharma_null_owasp.pptx
E-Vehicle_Hacking_by_Parul Sharma_null_owasp.pptxE-Vehicle_Hacking_by_Parul Sharma_null_owasp.pptx
E-Vehicle_Hacking_by_Parul Sharma_null_owasp.pptx
 
Swan(sea) Song – personal research during my six years at Swansea ... and bey...
Swan(sea) Song – personal research during my six years at Swansea ... and bey...Swan(sea) Song – personal research during my six years at Swansea ... and bey...
Swan(sea) Song – personal research during my six years at Swansea ... and bey...
 
Breaking the Kubernetes Kill Chain: Host Path Mount
Breaking the Kubernetes Kill Chain: Host Path MountBreaking the Kubernetes Kill Chain: Host Path Mount
Breaking the Kubernetes Kill Chain: Host Path Mount
 
The transition to renewables in India.pdf
The transition to renewables in India.pdfThe transition to renewables in India.pdf
The transition to renewables in India.pdf
 
AI as an Interface for Commercial Buildings
AI as an Interface for Commercial BuildingsAI as an Interface for Commercial Buildings
AI as an Interface for Commercial Buildings
 
CloudStudio User manual (basic edition):
CloudStudio User manual (basic edition):CloudStudio User manual (basic edition):
CloudStudio User manual (basic edition):
 
"LLMs for Python Engineers: Advanced Data Analysis and Semantic Kernel",Oleks...
"LLMs for Python Engineers: Advanced Data Analysis and Semantic Kernel",Oleks..."LLMs for Python Engineers: Advanced Data Analysis and Semantic Kernel",Oleks...
"LLMs for Python Engineers: Advanced Data Analysis and Semantic Kernel",Oleks...
 
#StandardsGoals for 2024: What’s new for BISAC - Tech Forum 2024
#StandardsGoals for 2024: What’s new for BISAC - Tech Forum 2024#StandardsGoals for 2024: What’s new for BISAC - Tech Forum 2024
#StandardsGoals for 2024: What’s new for BISAC - Tech Forum 2024
 
Pigging Solutions in Pet Food Manufacturing
Pigging Solutions in Pet Food ManufacturingPigging Solutions in Pet Food Manufacturing
Pigging Solutions in Pet Food Manufacturing
 
Vulnerability_Management_GRC_by Sohang Sengupta.pptx
Vulnerability_Management_GRC_by Sohang Sengupta.pptxVulnerability_Management_GRC_by Sohang Sengupta.pptx
Vulnerability_Management_GRC_by Sohang Sengupta.pptx
 
SIEMENS: RAPUNZEL – A Tale About Knowledge Graph
SIEMENS: RAPUNZEL – A Tale About Knowledge GraphSIEMENS: RAPUNZEL – A Tale About Knowledge Graph
SIEMENS: RAPUNZEL – A Tale About Knowledge Graph
 
Beyond Boundaries: Leveraging No-Code Solutions for Industry Innovation
Beyond Boundaries: Leveraging No-Code Solutions for Industry InnovationBeyond Boundaries: Leveraging No-Code Solutions for Industry Innovation
Beyond Boundaries: Leveraging No-Code Solutions for Industry Innovation
 
Kotlin Multiplatform & Compose Multiplatform - Starter kit for pragmatics
Kotlin Multiplatform & Compose Multiplatform - Starter kit for pragmaticsKotlin Multiplatform & Compose Multiplatform - Starter kit for pragmatics
Kotlin Multiplatform & Compose Multiplatform - Starter kit for pragmatics
 
Artificial intelligence in the post-deep learning era
Artificial intelligence in the post-deep learning eraArtificial intelligence in the post-deep learning era
Artificial intelligence in the post-deep learning era
 
Automating Business Process via MuleSoft Composer | Bangalore MuleSoft Meetup...
Automating Business Process via MuleSoft Composer | Bangalore MuleSoft Meetup...Automating Business Process via MuleSoft Composer | Bangalore MuleSoft Meetup...
Automating Business Process via MuleSoft Composer | Bangalore MuleSoft Meetup...
 
Maximizing Board Effectiveness 2024 Webinar.pptx
Maximizing Board Effectiveness 2024 Webinar.pptxMaximizing Board Effectiveness 2024 Webinar.pptx
Maximizing Board Effectiveness 2024 Webinar.pptx
 
Scanning the Internet for External Cloud Exposures via SSL Certs
Scanning the Internet for External Cloud Exposures via SSL CertsScanning the Internet for External Cloud Exposures via SSL Certs
Scanning the Internet for External Cloud Exposures via SSL Certs
 
Designing IA for AI - Information Architecture Conference 2024
Designing IA for AI - Information Architecture Conference 2024Designing IA for AI - Information Architecture Conference 2024
Designing IA for AI - Information Architecture Conference 2024
 

New Zealand Cervical Cancer Experiment

  • 1. “ The Unfortunate Experiment” a very abbreviated tale Rachel Walden
  • 2. Cervical Cancer a few terms, courtesy of the NCI Cervical cancer: Cancer that forms in tissues of the cervix (organ connecting the uterus and vagina). It is usually a slow-growing cancer that may not have symptoms, but can be found with regular Pap smears (procedure in which cells are scraped from the cervix and looked at under a microscope). Stage 0: The cancer is found only in the top layer of cells in the tissue that lines the cervix. Stage 0 is also called carcinoma in situ . Properly treated, tumor control of in situ cervical carcinoma should be nearly 100%. Punch biopsy : a sharp, hollow device is used to remove sample of cervical tissue. Cone biopsy: removes a cone-shaped sample of tissue.
  • 3. The Experiment Conducted at National Women’s Hospital, Auckland, New Zealand Headed by Dr. Herbert Green, OB/GYN at NWH, professor 948 patients with carcinoma in situ (CIS) of the cervix Women followed from 1955 to 1976; study officially began in 1966 To prove that CIS never develops into invasive cervical cancer, is not a premalignant condition To reduce number of major/invasive procedures to treat CIS, such as hysterectomy
  • 4. The Methodology NWH patients recruited with cervical CIS who were under 35 yo, there were to be no signs of invasive carcinoma Followed from 5 to 28 years Split into groups by normal (A) or abnormal (B) cytology at follow up Received cone biopsies and other diagnostic procedures – not complete cancer removal
  • 5. The Results 1.5% of group A and 22% of group B developed invasive cancer Women with continuing abnormal cytology 24.8 times more likely to develop invasive carcinoma In group A (normal follow-up), 3.2 times more likely to develop cancer than women who never had CIS Some women later died Green reclassified some of those who developed invasive cancer as having been missed initially
  • 6. The Controversy In 1987, women’s health activists published an article, “An Unfortunate Experiment,” in the Metro magazine outlining the study. This article focused on one patient, “Ruth,” who was followed from 1964 to 1979, and finally diagnosed with cervical cancer in 1985. Public outcry occurred, and judicial inquiry ordered by the Ministry of Health Cartwright inquiry – officially, “Committee of Inquiry into Allegations Concerning the Treatment of Cervical Cancer at National Women’s Hospital and into Other Related Matters,” headed by District Court Judge Silvia Cartwright 67 witnesses heard and >80 patients interviewed privately Report released August 5, 1988
  • 7. The Inquiry Findings Determined that the study was unethical: women not informed they were in a study; not informed of other treatment options; inadequately addressed risks to patients; symptoms of invasive disease downplayed or overlooked; some women never even told they had CIS Dr. Green maintained it was not in the women’s interests to tell them what he was doing Other revelations: medical students were doing vaginal exams on anaesthetized women without their knowledge or consent; >2,000 newborn females received cervical smears; some women later enrolled in R Series trial of differing treatments of invasive cancer without their knowledge
  • 8. The Inquiry, continued Early attempts at questioning the by the cytologist and pathologist program went nowhere – Superintendent-in-Chief of the Auckland Medical Board did not consider the matter “urgent” Other clinicians did not want to interfere with Dr. Green’s “clinical freedom” Cases of invasive cancer were identified in 1969, but trial continued Enrollment protocol not followed – women over 35 were included fairly regularly, invasive signs ignored Numerous recommendations for improvement: patient advocates, nationwide cervical cancer screening, improved informed consent, ethics
  • 9. Women’s Statements “I can’t explain the shock that I felt when I found out by accident that I had a cone biopsy.” “…I was never actually told that I had carcinoma in situ.” “After I had the cone biopsy I was told that they had got it all. I have since learnt that this was not the case. I was told that the chance of getting any form of cancer again were the same as any other woman.” “For instance, if I had known that my biopsy in 1975 showed that I had microinvasion, I would never have ceased to go to follow-up clinics.”
  • 10. Historical Context Declaration of Helsinki written in 1964; Nuremburg Code also in existence at time of study According to the Cartwright report: “By the early 1960s most experts in Europe, the United States of America and Australia considered that CIS was a precursor of invasive cervical cancer.” Indirect and direct evidence was in existence when study began that CIS could in fact lead to invasive cancer Less invasive management techniques were already gaining favor before 1966
  • 11. The Aftermath ~130 patients identified and contacted for follow-up. This was not perfect, as follow-up sometimes occurred in the course of routine clinical care, without women being provided with full details of their past enrollment into Dr. Green’s study Bureaucracy and resistance slows action on Cartwright report recommendations. Some physicians call informed consent procedures too burdensome. Cartwright Inquiry challenged, attacked as a “feminist witch hunt,” but later vindicated Some physicians investigated and fined. Dr. Green not punished due to poor health. Several women sue and receive damages. In the 1990s a related inquiry occurs, after it is found that abnormal cervical smear results have been vastly underreported in one region of the national cervical cancer screening program. More women die of cervical cancer as a result.
  • 12. Summary Study based on personal beliefs rather than established facts Informed consent – completely absent Lack of understanding and voluntariness Respect for persons – individuals not treated as autonomous agents Justice – subjects were chosen because they were available Beneficence – no efforts to minimize harm Questionable handling of adverse events Institutional safeguards broken/not followed Hypothesis disproved; trial continued
  • 13. Resources Campbell AV. A report from New Zealand: an ‘unfortunate experiment.’ Bioethics. 1989 Jan;3(1):59-66. Committee on Inquiry into Allegations Concerning the Treatment of Cervical Cancer at National Women’s Hospital and into Other Related Matters. Report of the Committee of Inquiry into Allegations Concerning the Treatment of Cervical Cancer at National Women’s Hospital and into Other Related Matters. Auckland: The Committee, 1988. Davis P. A fortunate inquest: the report of the cervical cancer inquiry. Community Health Stud. 1988;12(3):246-50. Coney S, ed. Unfinished business: what happened to the Cartwright Report?: writings on the aftermath of 'the unfortunate experiment' at National Women's Hospital. Auckland: Women’s Health Action, 1993. Coney S. The Unfortunate Experiment. Auckland: Penguin Books, 1988.
  • 14. Resources - 2 Flagler EA, Winkler ER. ‘An unfortunate experiment’: the New Zealand study of cancer of the cervix. Ann R Coll Physicians Surg Can. 1992 Apr;25(2):124-30. Heslop B. ‘All about research’ – looking back at the 1987 Cervical Cancer Inquiry. N Z Med J. 2004 Aug 6;117(1199):U1000. McIndoe WA, McLean MR, Jones RW, Mullins PR. The invasive potential of carcinoma in situ of the cervix. Obstet Gynecol. 1984 Oct;64(4):451-8. Munro K. The aftermath of the cervical caner inquiry in New Zealand: an antipodal aberration or universal struggle? Issues Reprod Genet Eng. 1991;4(1):31-9. Paul C. Internal and external morality of medicine: lessons from New Zealand. BMJ. 2000 Feb;320(7233):499-503.
  • 15. Resources - 3 Rosier P. The speculum bites back: feminists spark an inquiry into the treatment of carcinoma in situ at Auckland’s National Women’s Hospital. Reprod Genet Eng. 1989;2(2):121-32. Williams L. Looking back at the 1987 Cervical Cancer Inquiry. N Z Med J. 2004 Sep 24;117(1202):U1084; author reply U1084. Women’s Health Action Trust. Women’s Health Action [web document]. Auckland: The Trust. [rev. 28 Dec 2005; cited 18 Apr 2006]. <http://www.womens-health.org.nz/>
  • 16. Special Thanks to the EBL Document Delivery staff These amazing folks obtained a copy of the Cartwright Report, held by fewer than 20 libraries in the United States!